OBJECTIVE: Risk factors for susceptibility to bacterial meningitis have been identified, but basic causes of inter-individual differences in susceptibility are largely unknown. METHODS: To determine the effect of genetic variation in the complement system on susceptibility to bacterial meningitis we performed a prospective nationwide genetic association study in patients with community-acquired bacterial meningitis. We genotyped 17 common SNPs (minor allele frequencies >5%) in genes coding for complement components and evaluated functional consequences by measuring complement levels in the cerebrospinal fluid. RESULTS: From March 2006 to June 2009 we included 636 adults with community-acquired bacterial meningitis. DNA was available for 439 patients and 302 controls. Rs1047286 (Pro314Leu) in complement component 3 was associated with reduced susceptibility to bacterial meningitis after correction for multiple testing: the protective Leu/Leu genotype was found in 5 of 435 patients (1%) compared to 15 of 302 controls (5%; odds ratio [OR] 4.50, 95% confidence interval [CI] 1.62-12.50, p = 0.0017). Rs1047286 is in strong linkage disequilibrium with Rs2230199 (C3 Arg102Gly), of which the Arg/Arg genotype was associated with higher CSF levels of C3 and lower levels of C5a and terminal complement complex (TCC; soluble C5b-9), indicating decreased consumption of C3 and less activation of the complement system. Rs1047286 was associated with susceptibility albeit not significantly after Bonferroni correction (OR 1.37, 95% CI 1.01-1.87; p = 0.04). CONCLUSIONS: This study shows an association between a common single nucleotide polymorphism in C3 and susceptibility for community-acquired bacterial meningitis.
OBJECTIVE: Risk factors for susceptibility to bacterial meningitis have been identified, but basic causes of inter-individual differences in susceptibility are largely unknown. METHODS: To determine the effect of genetic variation in the complement system on susceptibility to bacterial meningitis we performed a prospective nationwide genetic association study in patients with community-acquired bacterial meningitis. We genotyped 17 common SNPs (minor allele frequencies >5%) in genes coding for complement components and evaluated functional consequences by measuring complement levels in the cerebrospinal fluid. RESULTS: From March 2006 to June 2009 we included 636 adults with community-acquired bacterial meningitis. DNA was available for 439 patients and 302 controls. Rs1047286 (Pro314Leu) in complement component 3 was associated with reduced susceptibility to bacterial meningitis after correction for multiple testing: the protective Leu/Leu genotype was found in 5 of 435 patients (1%) compared to 15 of 302 controls (5%; odds ratio [OR] 4.50, 95% confidence interval [CI] 1.62-12.50, p = 0.0017). Rs1047286 is in strong linkage disequilibrium with Rs2230199 (C3 Arg102Gly), of which the Arg/Arg genotype was associated with higher CSF levels of C3 and lower levels of C5a and terminal complement complex (TCC; soluble C5b-9), indicating decreased consumption of C3 and less activation of the complement system. Rs1047286 was associated with susceptibility albeit not significantly after Bonferroni correction (OR 1.37, 95% CI 1.01-1.87; p = 0.04). CONCLUSIONS: This study shows an association between a common single nucleotide polymorphism in C3 and susceptibility for community-acquired bacterial meningitis.
Authors: Sonata Jodele; Kejian Zhang; Fanggeng Zou; Benjamin Laskin; Christopher E Dandoy; Kasiani C Myers; Adam Lane; Jaroslav Meller; Mario Medvedovic; Jenny Chen; Stella M Davies Journal: Blood Date: 2015-11-24 Impact factor: 22.113
Authors: Evans Raballah; Samuel B Anyona; Qiuying Cheng; Elly O Munde; Ivy-Foo Hurwitz; Clinton Onyango; Caroline Ndege; Nicolas W Hengartner; Maria Andreína Pacheco; Ananias A Escalante; Christophe G Lambert; Collins Ouma; Henri C Jr T Obama; Kristan A Schneider; Philip D Seidenberg; Benjamin H McMahon; Douglas J Perkins Journal: Exp Biol Med (Maywood) Date: 2021-11-29
Authors: E Soemirien Kasanmoentalib; Mercedes Valls Seron; Bart Ferwerda; Michael W Tanck; Aeilko H Zwinderman; Frank Baas; Arie van der Ende; William J Schwaeble; Matthijs C Brouwer; Diederik van de Beek Journal: J Neuroinflammation Date: 2017-01-03 Impact factor: 8.322
Authors: Emma C Wall; Mavuto Mukaka; Matthew Scarborough; Katherine M A Ajdukiewicz; Katharine E Cartwright; Mulinda Nyirenda; Brigitte Denis; Theresa J Allain; Brian Faragher; David G Lalloo; Robert S Heyderman Journal: Clin Infect Dis Date: 2017-02-15 Impact factor: 9.079
Authors: Anne T Kloek; Jessica van Setten; Arie van der Ende; Michiel L Bots; Folkert W Asselbergs; Mercedes Valls Serón; Matthijs C Brouwer; Diederik van de Beek; Bart Ferwerda Journal: Sci Rep Date: 2016-07-08 Impact factor: 4.379